Will crowdfunding and general solicitation spur orphan drug development for biotechs?
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 343
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2013 AND VI 48 AND IP 10
Results: 23
1
2
Better adherence, lower healthcare costs for diabetes patients enrolled in value-based insurance designs.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 341
- By:
- Publication type:
- Article
3
Clear marking on pain patches required by FDA.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 340
- Publication type:
- Article
4
New formulation.
- Published in:
- 2013
- By:
- Publication type:
- Product Review
5
Pipeline preview.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 322
- Publication type:
- Article
6
Concerns about effectiveness of preservative lead to recall of dry-eye solution.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 339
- Publication type:
- Article
7
Oral oncolytics Part 2: Assessing the value of newer agents versus current standards of care as part of P&T processes.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 324
- By:
- Publication type:
- Article
8
FDA actions in brief.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 323
- Publication type:
- Article
9
First-time generic approvals.
- Published in:
- 2013
- Publication type:
- Product Review
10
Infant Motrin recalled because of possible contamination.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 339
- Publication type:
- Article
11
Antibiotic formulary guidelines for health systems: Balancing evidence and stewardship.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 332
- By:
- Publication type:
- Article
12
Cognitive enhancers don't help after 96 weeks in mild cognitive impairment for Alzheimer's patients.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 320
- By:
- Publication type:
- Article
13
Sunscreen recommendation rates low.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 320
- By:
- Publication type:
- Article
14
Location helps determine access to affordable, quality healthcare for Americans.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 319
- By:
- Publication type:
- Article
15
Mental 'fogginess' with tamoxifen use should be taken seriously.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 318
- By:
- Publication type:
- Article
16
Varenicline may help some patients with depression quit smoking.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 317
- Publication type:
- Article
17
Reducing adverse drug events by targeting at-risk patients.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 316
- By:
- Publication type:
- Article
18
Children who miss vaccinations at increased risk for whooping cough.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 316
- Publication type:
- Article
19
CDC seeks answer on e-cigarettes.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 315
- By:
- Publication type:
- Article
20
Kaiser Permanente's large-scale hypertension program nearly doubles BP control rates.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 314
- By:
- Publication type:
- Article
21
One quarter of heart disease deaths are preventable.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 313
- Publication type:
- Article
22
For children, skipped medications often lead to emergency department visits.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 313
- By:
- Publication type:
- Article
23
Some opioids linked to certain birth defects.
- Published in:
- Formulary, 2013, v. 48, n. 10, p. 311
- By:
- Publication type:
- Article